These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26513244)

  • 1. Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine.
    Jimenez-Guardeño JM; Regla-Nava JA; Nieto-Torres JL; DeDiego ML; Castaño-Rodriguez C; Fernandez-Delgado R; Perlman S; Enjuanes L
    PLoS Pathog; 2015 Oct; 11(10):e1005215. PubMed ID: 26513244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.
    Castaño-Rodriguez C; Honrubia JM; Gutiérrez-Álvarez J; DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Fernandez-Delgado R; Verdia-Báguena C; Queralt-Martín M; Kochan G; Perlman S; Aguilella VM; Sola I; Enjuanes L
    mBio; 2018 May; 9(3):. PubMed ID: 29789363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis.
    Jimenez-Guardeño JM; Nieto-Torres JL; DeDiego ML; Regla-Nava JA; Fernandez-Delgado R; Castaño-Rodriguez C; Enjuanes L
    PLoS Pathog; 2014 Aug; 10(8):e1004320. PubMed ID: 25122212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus virulence genes with main focus on SARS-CoV envelope gene.
    DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Castaño-Rodriguez C; Fernandez-Delgado R; Usera F; Enjuanes L
    Virus Res; 2014 Dec; 194():124-37. PubMed ID: 25093995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection.
    Gutiérrez-Álvarez J; Honrubia JM; Fernández-Delgado R; Wang L; Castaño-Rodríguez C; Zúñiga S; Sola I; Enjuanes L
    mBio; 2021 Mar; 12(2):. PubMed ID: 33653888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
    Menachery VD; Yount BL; Josset L; Gralinski LE; Scobey T; Agnihothram S; Katze MG; Baric RS
    J Virol; 2014 Apr; 88(8):4251-64. PubMed ID: 24478444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-Generation Live-Attenuated Candid#1 Vaccine Virus Resists Reversion and Protects against Lethal Junín Virus Infection in Guinea Pigs.
    Gowen BB; Hickerson BT; York J; Westover JB; Sefing EJ; Bailey KW; Wandersee L; Nunberg JH
    J Virol; 2021 Jun; 95(14):e0039721. PubMed ID: 33952638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines.
    Menachery VD; Gralinski LE; Mitchell HD; Dinnon KH; Leist SR; Yount BL; McAnarney ET; Graham RL; Waters KM; Baric RS
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29976657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
    Honrubia JM; Gutierrez-Álvarez J; Sanz-Bravo A; González-Miranda E; Muñoz-Santos D; Castaño-Rodriguez C; Wang L; Villarejo-Torres M; Ripoll-Gómez J; Esteban A; Fernandez-Delgado R; Sánchez-Cordón PJ; Oliveros JC; Perlman S; McCray PB; Sola I; Enjuanes L
    mBio; 2023 Feb; 14(1):e0313622. PubMed ID: 36625656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Basis of Coronavirus Virulence and Vaccine Development.
    Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
    Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.
    Netland J; DeDiego ML; Zhao J; Fett C; Álvarez E; Nieto-Torres JL; Enjuanes L; Perlman S
    Virology; 2010 Mar; 399(1):120-128. PubMed ID: 20110095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
    Cavanagh D
    Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
    Tseng CT; Sbrana E; Iwata-Yoshikawa N; Newman PC; Garron T; Atmar RL; Peters CJ; Couch RB
    PLoS One; 2012; 7(4):e35421. PubMed ID: 22536382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
    Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
    J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
    Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
    J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
    Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
    mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.